The Myklebost group arranged a succesful workshop for the EU "Network of Excellence on Bone Tumours", Research Line 2: "Osteogenic tumours and related sarcomas", in which they are Work Package Leaders. Thirty participants from ten European countries - including several clinicians from the National Competence Centre for Sarcomas - discussed progress and plans during a two-day meeting held June 10-12th at Lysebu Conference Centre.
From major journals, first or last author from the Institute for Cancer Research
Tanoli Z, Schulman A, Aittokallio T(2024) Validation guidelines for drug-target prediction methods Expert Opin Drug Discov, 1-15(in press) DOI 10.1080/17460441.2024.2430955, PubMed 39568436
Ullern A, Holm K, Røssevold AH, Andresen NK, Bang C, Lingjærde OC, Naume B, Hov JR, Kyte JA(2024) Gut microbiota diversity is prognostic and associated with benefit from chemo-immunotherapy in metastatic triple-negative breast cancer Mol Oncol(in press) DOI 10.1002/1878-0261.13760, PubMed 39545921
Pankiv S, Dahl AK, Aas A, Andersen RL, Brech A, Holland P, Singh S, Bindesbøll C, Simonsen A(2024) BEACH domain proteins function as cargo-sorting adaptors in secretory and endocytic pathways J Cell Biol, 223(12) DOI 10.1083/jcb.202408173, PubMed 39514288